Domestic Glove Sourcing for Federal Purchases

Summary#

The American Glove Act of 2026 would create a new law; it does not amend the Make PPE in America Act, but it adds requirements for certain federal nitrile-glove purchases that refer to that Act. Its stated goal is to ensure those purchases comply with domestic-sourcing and long-term-contracting requirements. It is an introduced bill, not law.

  • Covered federal agencies would have to structure covered purchasing arrangements so the gloves come exclusively from qualified domestic manufacturers. This includes the named departments and other executive agencies using shared purchasing arrangements.
  • A qualified domestic manufacturer must make the gloves in the United States at commercial scale, be majority-owned and controlled by U.S. persons, and not be owned, controlled, or significantly influenced by a foreign entity of concern.
  • The purchasing arrangement must include a written supplier agreement lasting at least two years, with a binding minimum purchase or other commercially reasonable demand commitment. It must also identify the manufacturer and facility and set pricing, delivery, quality, and performance terms.
  • Agencies generally must keep buying from the manufacturer named in the agreement during its term. Exceptions include the manufacturer’s written consent, material failure to perform, or another exception under federal procurement law; a substitution must be documented in a written agreement modification.
  • Agencies must keep a written compliance certification in the contract file and take corrective action under procurement law if they find noncompliance.
  • The bill preserves use of the AbilityOne Program and does not require removing gloves from its Procurement List or ending an AbilityOne arrangement solely because the gloves come from a qualified domestic manufacturer.

What it means for you#

  • Federal agencies: They would have to apply these requirements to covered purchasing arrangements, including existing arrangements in effect on or after the bill’s enactment. The bill says agencies should use existing procurement authority and does not require ending or re-bidding an arrangement if it can be brought into compliance another way.
  • Manufacturers and suppliers: To supply gloves through a covered arrangement, a manufacturer would need to meet the ownership, control, U.S. production, and capacity tests. The agreement must be directly enforceable between the manufacturer and the entity furnishing the gloves to the government.
  • AbilityOne participants and other intermediaries: The program and its purchasing arrangements may continue, but they cannot be used to avoid the domestic-sourcing or supplier-agreement requirements. The bill does not impose a separate statutory certification duty on AbilityOne or the other named non-agency participants.
  • The public: The bill does not directly change glove access, prices charged to the public, or eligibility for a public benefit.

Money#

No publicly available information on the bill’s cost.

  • The bill assigns compliance and recordkeeping duties to agencies but gives no estimate of staffing or administrative costs.
  • It specifies no new appropriation, fee, fine, or payment to manufacturers.

What is unclear#

  • The supplied materials do not include the Make PPE in America Act, so its existing requirements and how this bill would interact with them cannot be verified here.
  • The bill does not define “United States persons,” “foreign entity of concern,” “significant influence,” or “commercial scale.”
  • It does not set out a process or timeline for deciding whether a manufacturer qualifies, or how agencies should assess foreign influence.
  • “Commercially reasonable” demand commitments and “appropriate corrective action” are not further explained.
  • The bill does not say how many qualified manufacturers currently meet its tests or can supply the required volumes. No publicly available information.

Case for#

  • The bill appears intended to make sure domestic-sourcing rules reach the manufacturer, even when an intermediary or shared purchasing arrangement sits between the agency and manufacturer.
  • A two-year agreement with a minimum purchase commitment could give a domestic manufacturer clearer demand expectations for planning production.
  • Naming the manufacturer and facility, limiting substitutions, and requiring a contract-file certification could make sourcing easier to check.
  • The bill preserves AbilityOne arrangements, so agencies would not have to end them solely because a domestic manufacturer supplies the gloves.

Case against#

  • A possible trade-off is that agencies would be limited to manufacturers meeting strict ownership, control, and U.S.-production tests. The bill does not establish how many suppliers could qualify or whether they can meet agency demand.
  • The bill does not define key tests such as “significant influence” or explain how agencies should apply them, which could lead to uncertainty in procurement decisions.
  • Two-year agreements and minimum purchase commitments may limit agencies’ flexibility to change suppliers, though the bill allows specified exceptions.
  • The bill requires agency certifications and corrective action but does not specify oversight, reporting, or a detailed process for resolving disputes.